Idiopathic Gastroparesis
15
2
2
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
6.7%
1 terminated out of 15 trials
91.7%
+5.1% vs benchmark
20%
3 trials in Phase 3/4
45%
5 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 11 completed trials
Clinical Trials (15)
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.
Biomagnetic Characterization of Gastric Dysrhythmias III
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
Gastroparesis Registry 3
A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
Gastroparesis Registry 2
Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic Patients
Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants
G-POEM for Treatment of Refractory Gastroparesis
Nortriptyline for Idiopathic Gastroparesis
A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis
Effects of Global Osteopathic Manual Treatments in Patients With Idiopathic Gastroparesis